Yuling Luo

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Fremont, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Timothy White, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Yuling Luo

Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Common Stock
Shares / value
1,940,574
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Common Stock
Shares / value
1,224,152
Estimated value
Report date
20 Apr 2026
Price
Ownership
By Spouse
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Stock Option ((Right to Buy)
Shares / value
42,334
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
Report date
20 Apr 2026
Price
Ownership
By Spouse
Underlying class
Class B Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Underlying class
Class B Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Class B Common Stock
Shares / value
0
Estimated value
Report date
20 Apr 2026
Price
Ownership
By Spouse
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Class B Common Stock
Shares / value
0
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Founders Preferred Stock
Shares / value
0
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Underlying class
Class B Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Alamar Biosciences, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
20 Apr 2026
Price
Ownership
Direct
Underlying class
Class B Common Stock
Underlying amount

Insider Reports Filed by Yuling Luo

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .